Regulators and researchers are intensifying scrutiny of food and pharmaceutical preservatives. The FDA is assessing safety concerns around common additives like BHA while approving preservative-free drug formulations, as studies link certain preservatives to diabetes, hypertension, and cardiovascular disease.
·FDA launched formal safety review of BHA, a widespread food preservative, over cancer risk concerns
·Research links eight common food additives to high blood pressure and heart disease
·Study finds association between preservative additives and type 2 diabetes incidence in large prospective cohort
·FDA approves preservative-free ketamine formulation and bimatoprost gel for medical use
·Pharmaceutical companies launching preservative-free drug alternatives to address safety concerns
drawn from Nature, Vera Health, Optometry Times, Review of Optometry · updated 3d ago